A detailed history of Herold Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Herold Advisors, Inc. holds 5,350 shares of NVO stock, worth $598,879. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,350
Previous 5,950 10.08%
Holding current value
$598,879
Previous $763,000 -0.0%
% of portfolio
0.18%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$122.71 - $146.91 $73,626 - $88,146
-600 Reduced 10.08%
5,350 $763,000
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $97,004 - $129,123
950 Added 19.0%
5,950 $763,000
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $228,228 - $274,170
2,600 Added 108.33%
5,000 $517,000
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $218,256 - $478,896
2,400 New
2,400 $218,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Herold Advisors, Inc. Portfolio

Follow Herold Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.